Abstract:Objectives: Dental caries and periodontitis are among the most prevalent chronic diseases worldwide and have been associated with atherosclerotic cardiovascular diseases (ASCVD). This study aimed to determine (1) the independent associations between subclinical ASCVD markers (carotid intima media thickness [CIMT] and coronary artery calcification [CAC]) and quantitative indices of oral disease including the decayed, missing, and filled teeth (DMFT) index, gingivitis parameters, periodontal status, and number of teeth lost and (2) the extent to which metabolites altered in individuals with oral disease overlapped with those altered in individuals with ASCVD. Methods: We used data from 552 participants recruited through the Dental Strategies Concentrating on Risk Evaluation project. Oral examinations were conducted, and CIMT and CAC were measured. Multiple linear regression models were constructed with CIMT and CAC as dependent variables in the epidemiologic analysis. In the metabolomic analysis, logistic or linear regression was used to test 1,228 metabolites for association with each phenotype adjusted for age, sex, race, blood pressure, smoking, diabetes, cholesterol, high-sensitivity C-reactive protein, and interleukin-6. Results: None of the oral disease markers were significant predictors of ASCVD markers in the fully adjusted models. However, critical lipid and lipid-signaling pathway metabolites were significantly associated with gingivitis, periodontitis, and DMFT: the lysophospholipid pathway (odds ratio [OR] = 2.29, false discovery rate [FDR]-adjusted P = 0.038) and arachidonate with gingivitis (OR = 2.35, FDR-adjusted P = 0.015), the sphingolipid metabolism pathway with periodontitis (OR = 2.09, FDR-adjusted P = 0.029), and borderline associations between plasmalogen and lysophospholipid pathways and DMFT (P = 0.055). Further, the same metabolite from the sphingolipid metabolism pathway, sphingomyelin (d17:1/14:0, d16:1/15:0), was inversely associated with both CIMT (β = -0.14, FDR-adjusted P = 0.014) and gingivitis (OR = 0.04, FDR-adjusted P = 0.033). Conclusions: The discovery of a common sphingomyelin metabolite in both disease processes is a novel finding suggesting that gingivitis and periodontitis may be associated with some overlapping metabolic pathways associated with ASCVD and indicating potential shared mechanisms among these diseases. Knowledge transfer statement: The same metabolites may be altered in atherosclerosis and oral disease. Specifically, a common sphingomyelin metabolite was inversely associated with gingivitis and carotid intima media thickness, a subclinical marker of atherosclerotic cardiovascular disease. These findings can provide valuable insights for future mechanistic studies to establish potential causal relationships, with the hope of influencing disease prevention and targeted early treatment.

Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease

Serum metabolite signatures of cardiac function and morphology in individuals from a population-based cohort

Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes

Serum metabolomic profiling of incident type 2 diabetes mellitus in the Multi-Ethnic Study of Atherosclerosis and Rotterdam Study

Distinct Metabolites in Atherosclerosis Based on Metabolomics: A Systematic Review and Meta-analysis Primarily in Chinese Population

Large‐Scale Metabolomics and the Incidence of Cardiovascular Disease

Metabolomic study for the identification of symptomatic carotid plaque biomarkers

High-Dimensional Single-Cell Multimodal Landscape of Human Carotid Atherosclerosis

Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score

Serum Metabolic Signatures of Subclinical Atherosclerosis in Patients with Type 2 Diabetes Mellitus: a Preliminary Study

Comprehensive Metabolomic Characterization of Coronary Artery Diseases.

Dietary metabolic signatures and cardiometabolic risk

Integrating multi-modal omics to identify therapeutic atherosclerosis pathways for coronary heart disease

Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease

Associations Between Serum Metabolites And Subclinical Atherosclerosis In A Chinese Population: The Taizhou Imaging Study

Integrative Metabolomics Differentiate Coronary Artery Disease, Peripheral Artery Disease, and Venous Thromboembolism Risks

Single-Cell Transcriptomic Profiling Unveils Critical Metabolic Alterations and Signatures in Progression of Atherosclerosis

Spatial Metabolomics Identifies LPC(18:0) and LPA(18:1) in Advanced Atheroma With Translation to Plasma for Cardiovascular Risk Estimation

Microbiome and metabolome features of the cardiometabolic disease spectrum

Oral Disease and Atherosclerosis May Be Associated with Overlapping Metabolic Pathways

Metabolomics Profiling of Stages of Coronary Artery Disease Progression